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Pseudomonas aeruginosa is the most common bacterial pathogen infecting the lungs of cystic
fibrosis (CF) patients. The transmissible Liverpool epidemic strain (LES) harbours multiple inducible
prophages (LESu2; LESu3; LESu4; LESu5; and LESu6), some of which are known to confer a
competitive advantage in an in vivo rat model of chronic lung infection. We used quantitative PCR
(Q-PCR) to measure the density and dynamics of all five LES phages in the sputa of 10 LES-infected
CF patients over a period of 2 years. In all patients, the densities of free-LES phages were positively
correlated with the densities of P. aeruginosa, and total free-phage densities consistently exceeded
bacterial host densities 10–100-fold. Further, we observed a negative correlation between the phage-
to-bacterium ratio and bacterial density, suggesting a role for lysis by temperate phages in
regulation of the bacterial population densities. In 9/10 patients, LESu2 and LESu4 were the most
abundant free phages, which reflects the differential in vitro induction properties of the phages.
These data indicate that temperate phages of P. aeruginosa retain lytic activity after prolonged
periods of chronic infection in the CF lung, and suggest that temperate phage lysis may contribute
to regulation of P. aeruginosa density in vivo.
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Introduction
Cystic fibrosis (CF) patients are subject to life-long
chronic respiratory infections, most commonly with
the bacterium Pseudomonas aeruginosa. Periodic
exacerbation of symptoms occurs throughout the
lifetime of CF patients leading to progressive
deterioration of lung function. Phage particles have
been detected in the sputa of CF patients (Ojeniyi
et al., 1991; Fothergill et al., 2011). Metagenomic
analysis of CF sputa has identified 4450 viral
genotypes, whereas most viruses were unknown,
of those that could be identified as viruses the
majority were infective against CF pathogens,
including many Pseudomonas phages (Lim et al.,
2014). More generally, phages outnumber eukaryotic
viruses both in abundance and diversity in the
human virome (Reyes et al., 2012) and are known to
be present at various body sites including the
gastrointestinal (Breitbart et al., 2003; Kim et al.,
2011) and the respiratory tracts (Willner et al.,
2009). However, the in vivo ecological dynamics of
temperate bacteriophages and their role during
bacterial infections remain largely unknown.
Upon infection of a bacterial cell, a temperate
phage can either complete the lytic cycle or integrate
into the bacterial chromosome as a prophage, which
may subsequently be induced to enter the lytic cycle
by a range of bacterial or environmental cues (Little,
2005; Ghosh et al., 2009). Because lysis is obviously
detrimental to the individual host bacterium it is
often assumed that integrated prophages will even-
tually lose their lytic activity, becoming cryptic.
Whereas the selective forces and mechanisms driv-
ing this remain poorly understood, inactive proph-
age remnants have been detected in many bacterial
species, and are thought to result from an ongoing
process of phage decay (Brussow et al., 2004). This
could be owing to the accumulation of mutations;
for example, to inactivate phage N-antiterminator
genes (Desiere et al., 2001) and portal protein genes
(Lawrence et al., 2001), preventing completion of
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the replicative cycle. By contrast, lytic activity may
be retained if it enhances bacterial population
fitness, for example, by acting as an anticompetitor
strategy or through the release of virulence-related
toxins upon lysis (Brussow et al., 2004; Brown et al.,
2006; Willner et al., 2009). Over longer evolutionary
timescales, the domestication of prophages is
thought to be an important process in the evolution
of bacteria, leading to the origin of a number of
phage-derived traits (for example, bacteriocins,
killer particles etc.(Bobay et al., 2014)).
The P. aeruginosa Liverpool epidemic strain (LES)
exhibits increased antibiotic resistance levels com-
pared with other P. aeruginosa isolates from CF
patients (Ashish et al., 2012) and is widespread
across the UK (Martin et al., 2013). Patients infected
with this strain have been shown to suffer greater
morbidity than those infected with other strains
(Al-Aloul et al., 2004; Fothergill et al., 2012). The
P. aeruginosa LESB58 genome contains five induci-
ble prophages and transposon mutagenesis of this
isolate identified several mutations in prophages
encoding LESj2, LESj3 and LESj5 that reduced
bacterial competitiveness in a rat model of chronic
lung infection (Winstanley et al., 2009), suggesting
that the phages have a key role in the infection
process. We have previously characterised the
infection properties of several LES phages in vitro.
Induction experiments demonstrated that free
LESj2 was produced more rapidly and in higher
numbers than LESj3 and LESj4 in response to
norfloxacin. Each phage was shown to exhibit a
different immunity profile and was able to infect a
range of susceptible P. aeruginosa hosts (James et al.,
2012). Owing to a lack of suitable acceptor strains,
we have thus far been unable to isolate and purify
LESj5 and LESj6.
In this study, we used culture-independent quan-
titative PCR (Q-PCR) to follow the ecological
dynamics of all 5 active LES phage populations in
188 expectorated sputum samples from 10 long-term
LES-infected patients over a period of 28 months. To
our knowledge, this represents the first longitudinal
study of a bacterial pathogen and its temperate
phages in a human chronic infection.
Materials and methods
Patients and Samples
Sputum samples (n¼ 188) were collected from 10
LES-infected CF patients for diagnostic purposes
over a period of 42 years (January 2009 to May
2011). The details of each patient and the sampling
rationale have been described previously (Fothergill
et al., 2010; Mowat et al., 2011). All patients had
long-term LES infections (duration at beginning of
the study ranged from45 to410 years). Table 1 and
Supplementary Figure S1 describe the number and
dates of acquired samples from each patient that
were analysed for density of LES bacteria and LES
phages. During routine visits 98 samples were
collected when each patient was well (stable) and
90 samples were collected during periods of acute
exacerbated symptoms of respiratory infection
(acute). Sputa obtained during exacerbation periods
included samples taken before and during aggres-
sive intravenous antibiotic treatment (Table 1,
Supplementary Figure S1). The criteria for diagnos-
ing exacerbations were physician-based and have
been described previously (Mowat et al., 2011).
Briefly, patients were considered to be undergoing
an exacerbation if they showed signs of reduced
lung capacity, increased sputum production and
discoloration, increased temperature, cough, dys-
pnoea and malaise (Goss and Burns, 2007). Where
known, antibiotics administered to patients during
the study period are listed in Table 1. However,
detailed information of the antibiotics administered
during each exacerbation is very incomplete.
Table 1 Patient LES phage complement and sputum sample summary
Patient j Complement Total Stable Exacerbation Antibiotics
CF1 3, 4, 6 17 14 3 TOB (N), AZT (O)
CF2 2, 3, 4, 6 11 9 2 CEPH (O), CEF (IV), COL (IV)
CF3a 2, 3, 4, 6 7 1 6 AZT (O), COL (N), CEF (IV), COL (IV)
CF4 2, 3, 4, 6 14 10 4 CEF (IV), COL (IV)
CF5 2, 3, 4, 6 10 7 3
CF6 2, 3, 4, 6 16 9 7 AZT (O), COL (N)
CF7a 2, 3, 4, 5, 6 28 11 17 AZT (O), COL (N), CEF (IV), COL (IV), MER (IV), FOS (IV)
CF8 2, 3, 4, 5, 6 33 8 25 CEPH (O), FOS (IV), MER (IV), CEF (IV)
CF9 2, 3, 4, 5, 6 25 19 6 AZT (O), COL (N), TOB (N), MER (IV), COL (IV)
CF10 2, 3, 4, 5, 6 27 10 17 MER (IV), COL (IV)
Total 188 98 90
Abbreviations: AZT, azithromycin; CF, cystic fibrosis; CEPH, cephadrine; CEF, ceftazidime; COL, colomycin; FOS, fosfomycin; IV, intravenous
(used during exacerbations only); LES, Liverpool epidemic strain; MER, meropenem; N, nebulised; O, oral; TOB, tobramycin.
CF patient sputum contained LES variants that harboured different phage complements. Stable samples were collected during periods of relative
patient health. Exacerbation samples were collected during periods of reduced lung function and hospitalisation of patients, who underwent
antibiotic treatment for which data are incomplete. Antibiotics used during the period of the study are shown (where known): Route of
administration is indicated in brackets.
aPatients CF3 and CF7 died before completion of this study.
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Thus we were unable to fully assess the effect of
different antibiotics on phage induction in vivo.
This study was approved by the local Research
Ethics Committee (REC reference 08/H1006/47).
Detection of viable phage particles by plaque assay
We were unable to accurately determine phage
densities by culture-dependent techniques for
several reasons: (a) we lacked acceptor strains
for LESj5 and LESj6; (b) culturable phages were
indistinguishable by plaque morphology; and
(c) sputum samples were routinely frozen upon
collection, which reduced phage viability. However,
to confirm the presence of viable phage particles
in sputum samples, we quantified the density of
culturable phages in 10 sputum samples from 3 LES-
infected patients (CF3, CF4 and CF7). Sputum
samples (50 ml) were treated with sputasol (200 ml)
and incubated at 37 1C for 1 h, with shaking at
200 r.p.m. Treated samples were diluted with sterile
phosphate-buffered saline. A rifampicin-resistant
mutant (PAO1-rif) was created by successive passage
in increasing rifampicin concentrations (method
described by James et al., 2001). This enabled
enumeration of active phages capable of infecting
PAO1 directly from unfiltered sputum. Briefly, mid-
exponential phase PAO1-rif (OD600 0.5; 100 ml) was
added as an indicator host to treated sputum
samples (400 ml). Rifampin (300mgml 1) was incor-
porated in the soft agar overlay (5ml; 0.4% (w/v)
Luria broth (LB) agar) to select for the indicator host
and incubated overnight at 37 1C before the plaques
were counted. This method only provides confirma-
tion that active P. aeruginosa phages are present in
the sputa. It does not accurately reflect abundance
and does not discriminate between phages.
Real-time Q-PCR
To overcome the limitations of culture-dependent
methods, we have developed and validated a simple
Q-PCR protocol to measure the density of each
individual LES phage (James et al., 2012). Each
sputum sample was treated with an equal volume of
Sputasol (Oxoid, Basingstoke, UK) and incubated at
37 oC for 30min, with shaking at 200 r.p.m. DNAwas
prepared from each treated sputum sample (400 ml)
using the ‘Qiasymphony Virus/Pathogen DNA
extraction kit’ (Qiagen, Valencia, CA, USA) and the
automated QIAsymphony machine (QIAGEN;
pathogen complex 200 protocol). The protocol
yielded 0.3–0.9mg ml1 DNA. Each sample was
diluted 1:100 with sterile distilled H2O. The number
of DNA copies of each LES phage in sputum and
bacterial culture samples was quantified from
extracted DNA. The number of specific copies
detected for each phage was compared with a
concentration gradient of known standards (James
et al., 2012). For each LES phage (LESj2–LESj6),
two specific primer sets were used to quantify i)
prophage and ii) total copies (10 primer sets in
total). Differentiation between total phage and
prophage copies, allowed free-phage densities to
be calculated as the difference between these values
as previously described (James et al., 2012). Bacter-
ial host density was quantified using primers
specific for P. aeruginosa (PS21-6F1/PS21-6R1 and
gyrPA-F1/gyrPA-R1) (Fothergill et al., 2013). All
primer sequences and targets are listed in
Supplementary Table S1.
Q-PCR reactions (25 ml) contained 1 mM each
primer pair and 1X Rotorgene-SYBR green super-
mix (Qiagen). All primer sets were used with the
same cycling conditions: 95 1C for 10min; followed
by 40 cycles of 95 1C for 10 s, 60 1C for 15 s and 72 1C
for 20 s. Phage DNA copy numbers were quantified
from DNA samples (1 ml) in triplicate using a
Rotorgene cycler (Qiagen). Q-PCR data were
analysed using Rotorgene Q series software
1.7 (Qiagen).
Sputasol induction experiments
To test for any potential induction properties of
sputasol, DNA was extracted from LESB58 cultures
grown to mid-exponential phase in LB (James et al.,
2012) treated (in triplicate) with an equal volume of
sputasol or LB for 30min. DNA was prepared from
each culture using a DNA mini kit (Qiagen) and
phage densities estimated by Q-PCR as described for
the sputum samples. No effect of sputasol on phage
induction was observed (Supplementary Figure S2).
Statistical analysis
To model phage densities (or phage-to-bacterium
ratios), we fitted linear mixed effects models
with maximum likelihood using the R package
nlme (Pinheiro and Bates 2000) with and without
temporal autocorrelated errors (an ARMA(1) model).
Models with temporal autocorrelated errors were
significant improvements over those without,
and therefore we present only these models below.
We included a random effect for patient ID and fixed
effects for time, exacerbation, bacterial load and the
interaction between bacterial load and exacerbation.
We compared full models with and without tempo-
rally autocorrelated errors using a likelihood ratio
test, and then used a backwards stepwise process
to remove nonsignificant fixed effects until the
minimum adequate model was identified. Models
analysing normalised variables gave similar results
to those analysing non-normalised data and are
presented in the supplementary information
(Supplementary Table S2a).
Results
Dynamics of total free-phage abundance
Plaque assays confirmed the presence of viable
particles of the subset of culturable phages
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in all sputum samples that were tested
(range 1.25 102–1.39 104 PFUml 1). Free-LES
phage DNA was detected in all patient sputa
(9.35 104–5.54 109 copies ml 1) and, in general,
total free-phage density (that is, the sum of all the
free-LES phages present in the sample) exceeded
that of P. aeruginosa within each sample
(mean range 11-fold to 90-fold) (Figure 1 and
Supplementary Table S3). We observed a positive
linear relationship between total free-phage density
and bacterial density (Figure 2a and Supplementary
Table S2b; bacterial coefficient 0.607 ± 0.054,
LRT¼ 85.9, d.f.¼ 1, Po0.001), consistent with
ongoing lytic activity by the temperate phages, but
no effect of time or exacerbations on total free-phage
densities. Further, we observed a negative linear
relationship between the phage-to-bacterium ratio
and bacterial density (Figure 2b and Supplementary
Table S2c bacterial coefficient -3.206± 0.484,
LRT¼ 108.4, d.f.¼ 1, Po0.001), suggesting a role
for phage lysis in regulation of bacterial densities.
Time and exacerbations had no significant effect on
phage-to-bacterium ratios. It is perhaps surprising
that exacerbations were not associated with either a
change in phage densities or a change in the phage-
to-bacterium ratio (Figure 3), given that these
episodes are associated with the administration
of high-dose intravenous antibiotics. However, it
should be noted that these patients were all subject
to variable cocktails of antibiotics over several years
irrespective of exacerbations (Table 1). Moreover,
clinical data on antibiotic use in these patients was
too incomplete to be used in analyses, and therefore
effects of particular antibiotics on phage dynamics
may have been missed.
Abundance heirarchy among individual phages within
lungs
Next, we considered each phage individually,
observing a general hierarchy of free-phage densi-
ties, though the precise patterns were clearly
influenced by the fact that the LES populations for
each patient did not all share the same prophage
complement (Table 1). Figure 4 illustrates the free-
phage densities of individual LES phages for each of
the patients. In the majority of patients (CF2–CF9)
similar free-phage dynamics were observed, in that
the density of free LESj2 was consistently higher
than that of the other LES phages, closely followed
by LESj4 (Figure 4). A positive correlation was
observed between LESj2 and LESj4 densities in
these patients (Supplementary Table S4). The
dynamics observed in samples from patient CF10
(Figure 3) exhibited a change in the hierarchy of free
phage, with considerably higher free-LESj4 densi-
ties observed. Despite consistent carriage of LES
prophage 3, very little free LESj3 was detected in
patients CF2–CF10. However, higher levels of
free LESj3 (3.29 107 copies ml1) were observed in
all sputa from patient CF1 (Figure 4), whose
P. aeruginosa were the only populations not to carry
prophage 2 (Table 1). We showed previously
that LES populations exhibit genotypic diversity,
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Figure 1 Longitudinal dynamics of total free-phage density and P. aeruginosa density in 10 CF patients. Q-PCR assays were used to
enumerate free-LES phage (dotted line) and P. aeruginosa (solid line) densities from the sputa of 10 LES-infected CF patients (CF1–CF5
left to right top row and CF6–CF10 left to right bottom row) over a 2-year period. Samples were obtained from patients both during stable
periods (black symbols) and during exacerbation of symptoms (red symbols). The dotted line represents the mean values of all free-LES
phages (2,3,4,5 and 6) for each patient. The density of free-phage copies of each LES phage was calculated by subtracting prophage copies
from total phage copies in each case.
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including variation in carriage of LES prophages.
In particular, the carriage of LES prophage 5 was not
consistent in all individuals of a given LES popula-
tion (Fothergill, et al., 2010). In this study, prophage
5 was intermittently detectable in the sputum from
patients 7 (up to 105 copies ml1) and 10 (102–104
copies ml1). This explains the low density of free
LESj5 in these patients. Free copies of LESj6 were
not detected in the majority of sputum samples.
Where free copies were detected, the density was
lower than the host bacterial load (6.7 103–1 107
copies ml1).
Discussion
The levels of free-LES phages detected in all
patients throughout this study suggest an active
lytic cycle that may be promoted by the presence
of H2O2 or DNA-damaging antibiotics in the CF
lung (McGrath et al., 1999; Fothergill et al., 2011).
Surprisingly, we observed no effect of patient
exacerbation on total free-phage density, although
this is consistent with previous studies showing that
neither fluctuations in P. aeruginosa populations
(Mowat et al., 2011), nor in the wider bacterial
population (Fodor et al., 2012), show any relation-
ship with the exacerbation period in chronically
infected patients, despite the use of high-level
intravenous antibiotic therapy. It is known that
particular antibiotics can induce phage lysis and it
is possible that different antibiotics regimes may
have influenced differential induction of phages
between patients. Indeed, we have shown pre-
viously that LES induction varies in response to
different antibiotics (Fothergill et al., 2011). Unfor-
tunately, because records of antibiotic treatments for
these patients were very incomplete, we were
unable to explicitly test for effects of particular
antibiotics in this study. This would in any case
be difficult because of the extensive and varied use
of antibiotics in this group of patients (Table 1),
which was not restricted to periods of exacerbation.
Our data do however suggest that ongoing phage
lysis may have a role in regulating bacterial density
in the CF lung. Treatments that induced the lytic
cycle of temperate phages could therefore offer a
promising alternative or addition to standard anti-
biotic therapies, which in themselves often do not
successfully reduce P. aeruginosa densities in long-
term chronically infected patients (Foweraker, 2009;
Mowat et al., 2011). Several studies have demon-
strated effective phage-antibiotic synergism in the
reduction of bacterial numbers in vitro and in vivo
(Hagens et al., 2006; Comeau et al., 2007; Knezevic
et al., 2013). However, this strategy would need to be
considered with caution. Antibiotic therapies that
induce stx phages of Shiga-toxigenic E. coli have
been shown to increase expression of Shiga toxin
genes that are encoded in the late region of the
phage genome and thus increase cytotoxic damage
and exacerbate symptoms (Matsushiro et al., 1999).
Although we have not identified any obvious
virulence factors encoded in the late gene region of
the LES phages (Winstanley, et al., 2009; James,
et al., 2012), we cannot ignore the possibility
that the lytic cycle might induce upregulation of
virulence genes.
We demonstrate here that LESj2 was the most
abundant free phage in 9-out-of-10 LES-infected
patients. The hierarchy of free-LES phage in patient
sputa was also observed in our previous studies of
LES phage induction in in vitro bacterial cultures
(James et al., 2012). This suggests therefore that
LESj2 is generally more readily induced or exhibits
a more efficient lytic cycle than the other phages
both in vitro and in vivo. In the sputa of patient CF1,
who was infected by a LES that lacked prophage 2,
LESj3 reached far higher abundances than observed
in other patients, suggesting potential suppression
of LESj3 lysis by LESj2 in vivo. In accordance
with our previous in vitro observations of coinduc-
tion of lysis by prophages, we observed a degree of
synchronisation of free-phage dynamics in vivo,
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suggesting that the phages may be responding to
shared signals, which could include a wide variety
of human host, bacterial and environmental triggers
(Little, 2005). It is exceptionally difficult to disen-
tangle to drivers of microbial dynamics in vivo due
to the complexity of host microenvironments; future
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Figure 3 Phage density and phage-to-bacterium ratio are not affected by exacerbations. Outlier box-plots display phage density (upper
panel) or phage-to-bacterium ratio (lower panel) in sputa from patients during stable periods (black) and exacerbations (red).
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Figure 4 Densities of individual LES phage types in patient sputa exhibit hierarchical trends. The free-phage densities, calculated for
each individual LES phage in the 10 CF patients analysed (CF1–CF5 left to right top row, and CF6–CF10 left to right bottom row). Each
line represents one LES phage type; LESj2 (blue); LESj3 (cyan); LES j4 (pink); LES j5 (green); LES j6 (orange); and P. aeruginosa (black
circles). All Q-PCR assays were performed in triplicate and mean values are presented. The density of free-phage copies of each LES
phage was calculated by subtracting prophage copies from total phage copies in each case.
Phage dynamics in chronic infection
C James et al
1396
The ISME Journal
studies using laboratory models of the infection
environment allowing the constituent drivers to be
decomposed will be necessary to elucidate this
(Wright et al., 2013; Fothergill et al., 2014).
The long-term maintenance of intact, active
temperate phages in the LES genome despite
substantial cell lysis suggests some selective or
competitive advantage in vivo, consistent with
previous work highlighting a loss of competitive-
ness observed following the introduction of muta-
tions to some LES prophage regions (Winstanley
et al., 2009). One possibility is that free-phage
particles produced by a subpopulation of LES could
kill competing bacteria (Brown et al., 2006). Indeed,
LESj2, LESj3 and LESj4 are capable of infecting
and lysing other clinical P. aeruginosa isolates
(James et al., 2012). Thus frequent induction of
the lytic cycle may enhance the competitive ability
of LES by promoting superinfection, which has been
observed clinically (McCallum et al., 2001), and
preventing invasion of the lung by other strains of
P. aeruginosa. Alternatively the prophages may
contain accessory genes that contribute directly to
LES fitness in the CF lung, which are only expressed
during the lytic cycle, as observed for other patho-
gens (Wagner et al., 2001).
Little is known about the consequences for the
human host of the presence of large numbers of
phage in the lung. However, high titre phage
preparations have recently been found to interact
with the immune system in vivo (Letkiewicz et al.,
2010). It has also been suggested that, following
adherence to mucous, some phages may act as a
form of innate host immunity enhancing host
defences against bacterial pathogens (Barr et al.,
2013). Our findings of high free-phage abundances
in CF lungs highlight the urgent need for research
into the interaction of phages with host immunity,
particularly in CF where dysfunctional immune
responses contribute to pathological processes.
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